Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults: A Randomized Clinical Trial

March 18, 2022

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2790261 

Question  What are the risks and benefits of obtaining a medical marijuana card for adults who seek medical marijuana for pain, insomnia, and anxiety or depressive symptoms?

Findings  In this randomized clinical trial involving 186 participants, immediate acquisition of a medical marijuana card increased the incidence and severity of cannabis use disorder (CUD) and resulted in no significant improvement in pain, anxiety, or depressive symptoms, but improved self-reported sleep quality.

Meaning  Findings from this study suggest the need for further investigation into the benefits of medical marijuana card ownership for insomnia symptoms and the risk of CUD, particularly for those with anxiety or depressive symptoms.


Popular posts from this blog

Managing Patients Taking Xylazine-Adulterated Opioids in Emergency, Hospital, and Addiction Care Settings

Wednesday, June 14, 2023 .   In response to the rapid escalation in the detection of xylazine in the unregulated drug supply, in April 2023, the White House designated fentanyl contaminated with xylazine an "emerging threat". The National Institute on Drug Abuse (NIDA) Center for the Clinical Trials Network (CCTN) convened health care professionals and federal partners to review current practices in xylazine-related testing, treatment, and wound care to inform evolving best-practices in the field. This convening focused on the most critical areas of concern with the goal of rapidly identifying current practices and a xylazine-opioid research agenda.   https://nida.nih.gov/news-events/meetings-events/2023/06/managing-patients-taking-xylazine-adulterated-opioids-emergency-hospital-addiction-care-settings
Read more

Prescription Drug Misuse and Addiction: Compassionate Care for a Complex Problem

This CME activity provides a practical approach to the management of prescription drug misuse and addiction, including how to use the clinical interview and CURES (California's Prescription Drug Monitoring Program) to identify if a problem exists, and how to intervene once the problem has been identified. Animated didactic videos, interactive slides, and video case scenarios will be used to put these principles into practice with a treatment algorithm. The most compassionate approach to tapering patients down and off the medication they are misusing will also be discussed.   https://edhub.ama-assn.org/stanford-medicine-cme/provider-referrer/14533
Read more

International Overdose Awareness Day, August 31

https://www.cdc.gov/drugoverdose/awareness/ioad.html August 31 marks  International Overdose Awareness Day   (IOAD) , the world’s largest annual campaign to end overdose. It’s a day to: Remember  loved ones who have died from drug overdose and acknowledge the grief of the family and friends left behind. Take action  to encourage support and recovery for everyone impacted by substance use and overdose. End overdose  by spreading awareness of overdose prevention strategies. Hashtags : #IOAD2023 #EndOverdose
Read more